pmedform1520090810.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
OF THE SECURITIES ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number:  0-28498
 
PARADIGM MEDICAL INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)
 
2355 South 1070 West
Salt Lake City, Utah 84119
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
 
Common Stock, par value $.001 per share
(Title of each class of securities covered by this form)
 
None
(Titles of all other classes of securities for which a duty to file reports under
Section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
 o
 
Rule 12g-4(a)(2)
 x
 
Rule 12h-3(b)(1)(i)
 o
 
Rule 12h-3(b)(1)(ii)
 o
 
Rule 15d-6
 o
 
Approximate number of holders of record as of the certification or notice date:  471
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Paradigm Medical Industries, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
 
  /s/  Stephen L. Davis
Date:  August 10, 2009
By:
Stephen L. Davis
   
President, Chief Executive Officer and Treasurer



Instruction:  This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934.  The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed.  It may be signed by an officer of the registrant, by counsel or by any other duly authorized person.  The name and title of the person signing the form shall be typed or printed under the signature.